| Pharmaceutical active ingredients: |
| HydrochlorothiazideMetoprolol Tartrate |
| Available forms, composition and doses of Betaloc Comp: |
| N / A |
| Betaloc Comp medical category: |
| Human:Beta-adrenergic blocking agentsDiuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC07BB02 - Metoprolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Zok-Zid | Hydrochlorothiazide; Metoprolol Succinate | Pfizer |
| Selokomb | Hydrochlorothiazide; Metoprolol Succinate; Metoprolol Tartrate | Pfizer |
| Selopress | Hydrochlorothiazide; Metoprolol Succinate; Metoprolol Tartrate | AstraZeneca |
| Azumetop HCT | Hydrochlorothiazide; Metoprolol Tartrate | Sandoz; Azupharma |
| Beloc Comp | Hydrochlorothiazide; Metoprolol Tartrate | AstraZeneca; Sanova Pharma |
| Co-Betaloc | Hydrochlorothiazide; Metoprolol Tartrate | Pfizer |
| CP-Metolol Co | Hydrochlorothiazide; Metoprolol Tartrate | Christo Pharmaceuticals |
| Diubeloc | Hydrochlorothiazide; Metoprolol Tartrate | AstraZeneca |
| Lopresor HCT | Hydrochlorothiazide; Metoprolol Tartrate | Novartis |
| Lopressor HCT | Hydrochlorothiazide; Metoprolol Tartrate | Novartis |